As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna headquarters in Cambridge, Massachusetts.Moderna’s first-quarter revenue was slashed nearly in half over the course ...
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
Moderna stock fell 2.32% on April 3 due to concerns over a patent infringement complaint from Arbutus Biopharma. Despite challenges in 2023, Moderna anticipates reasonable revenue in 2024, with a ...
At its annual Vaccines Day and Business Update on Wednesday, Moderna (MRNA) sought to show analysts and investors just how much its pipeline has advanced, four years after making history by ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
Do you have questions surrounding COVID-19, the vaccine and impacts on our communities? ABC13 is committed to finding answers and connecting you with resources. Man deliberately gets 217 Covid ...
A Victorian coroner is investigating whether a young woman's death from heart inflammation after receiving her third Covid-19 jab was caused by the Moderna vaccine. Moderna's lawyers appeared ...
A scientific journal published by Elsevier has reportedly posted a stunning 101 expressions of concern on studies connected to Didier Raoult, a disgraced French microbiologist who gained ...
One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...